Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications increased consumption fruit vegetables primary prevention cardiovascular diseases–
… of Cochrane reviews looking at interventions for the primary prevention of cardiovascular disease. Dr. Hartley has a PhD in Public …
… are a second-line treatment for this condition, but an increased mortality has been observed. The FDA, therefore, …
… and gain market access for products to treat infectious diseases and complications arising from treatment of infectious diseases. Recent projects have included: Conjoint analyses …
… Autoimmune Diseases A Wealth of Experience We have collaborated with our clients on projects to research autoimmune diseases, autoimmune treatments, and complications and … and gain market access for products to treat autoimmune diseases and complications arising from treatment of …
Literature Reviews and Meta-analyses We conduct literature reviews and meta-analyses using the most rigorous methodologies, so you get reliable and reproducible answers to your research questions. High-quality literature reviews can help you understand: …
… analysis Our Approach From design to deliverables, publications , and ongoing support, we develop and validate … and transparent model Developing documents and publications to communicate the value of your product …
A Cost-Effectiveness Analysis Using Real-World Data William Herring, PhD Director, Health Economics RTI Health Solutions A Cost-Effectiveness Analysis Using Real-World Data from the MSBase Registry: Comparing Natalizumab to Fingolimod in Patients with …
… medicines, vaccines, or diagnostics for communicable diseases, you need to consider additional factors such as …
… About Target Trial Emulation to Evaluate Drugs for Rare Diseases Share on: Tuesday, February 6 - Wednesday, February … used to evaluate the safety and efficacy of drugs for rare diseases or conditions. NASEM has invited Xabier Garcia de … when evaluating the safety and efficacy of drugs for rare diseases and conditions FDA and EMA engagement of people with …
IPECAD Cross Comparison Challenge on Cost-Effectiveness Models in Alz Disease and Related Dementias William L Herring, PhD Executive Director, Health Economics Transcript As disease-modifying therapies for Alzheimer’s disease, or AD, enter the market, …